Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 9 studies | 34% ± 16% | |
lung | 8 studies | 22% ± 5% | |
eye | 4 studies | 24% ± 10% | |
intestine | 4 studies | 21% ± 7% | |
adipose | 4 studies | 18% ± 1% | |
peripheral blood | 3 studies | 22% ± 4% | |
bone marrow | 3 studies | 18% ± 1% | |
liver | 3 studies | 36% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 7467.36 | 1445 / 1445 | 100% | 63.02 | 183 / 183 |
intestine | 100% | 8054.31 | 966 / 966 | 100% | 64.77 | 527 / 527 |
lung | 100% | 8891.18 | 578 / 578 | 100% | 55.24 | 1155 / 1155 |
ovary | 100% | 8691.31 | 180 / 180 | 100% | 44.14 | 430 / 430 |
stomach | 100% | 6354.67 | 359 / 359 | 100% | 59.93 | 286 / 286 |
breast | 100% | 9572.47 | 459 / 459 | 100% | 70.23 | 1116 / 1118 |
uterus | 100% | 8683.28 | 170 / 170 | 100% | 58.41 | 458 / 459 |
bladder | 100% | 7523.43 | 21 / 21 | 100% | 55.71 | 502 / 504 |
prostate | 100% | 7057.69 | 245 / 245 | 100% | 50.69 | 500 / 502 |
pancreas | 100% | 5229.70 | 328 / 328 | 99% | 48.48 | 176 / 178 |
thymus | 100% | 7845.75 | 653 / 653 | 99% | 41.62 | 598 / 605 |
skin | 100% | 11006.79 | 1809 / 1809 | 98% | 59.89 | 464 / 472 |
brain | 98% | 3725.72 | 2585 / 2642 | 100% | 43.45 | 705 / 705 |
kidney | 100% | 5760.61 | 89 / 89 | 98% | 37.81 | 881 / 901 |
adrenal gland | 100% | 5862.40 | 258 / 258 | 94% | 28.33 | 217 / 230 |
liver | 100% | 3388.83 | 225 / 226 | 91% | 22.42 | 369 / 406 |
adipose | 100% | 8868.82 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 6591.82 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 51.94 | 29 / 29 |
spleen | 100% | 8025.86 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 56.63 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 22.37 | 1 / 1 |
muscle | 100% | 4451.71 | 801 / 803 | 0% | 0 | 0 / 0 |
heart | 97% | 4254.93 | 838 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 93% | 30.10 | 74 / 80 |
peripheral blood | 77% | 5135.99 | 718 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006397 | Biological process | mRNA processing |
GO_0051607 | Biological process | defense response to virus |
GO_0043279 | Biological process | response to alkaloid |
GO_0000398 | Biological process | mRNA splicing, via spliceosome |
GO_0008380 | Biological process | RNA splicing |
GO_0043123 | Biological process | positive regulation of canonical NF-kappaB signal transduction |
GO_0042742 | Biological process | defense response to bacterium |
GO_0009636 | Biological process | response to toxic substance |
GO_0140374 | Biological process | antiviral innate immune response |
GO_0005730 | Cellular component | nucleolus |
GO_0005622 | Cellular component | intracellular anatomical structure |
GO_0005681 | Cellular component | spliceosomal complex |
GO_0016607 | Cellular component | nuclear speck |
GO_0005654 | Cellular component | nucleoplasm |
GO_0071008 | Cellular component | U2-type post-mRNA release spliceosomal complex |
GO_0005689 | Cellular component | U12-type spliceosomal complex |
GO_0005634 | Cellular component | nucleus |
GO_0004386 | Molecular function | helicase activity |
GO_0003724 | Molecular function | RNA helicase activity |
GO_0008186 | Molecular function | ATP-dependent activity, acting on RNA |
GO_0005524 | Molecular function | ATP binding |
GO_0003723 | Molecular function | RNA binding |
GO_0003725 | Molecular function | double-stranded RNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0016887 | Molecular function | ATP hydrolysis activity |
Gene name | DHX15 |
Protein name | ATP-dependent RNA helicase DHX15 (EC 3.6.4.13) (ATP-dependent RNA helicase #46) (DEAH box protein 15) (Splicing factor Prp43) (hPrp43) |
Synonyms | DBP1 DDX15 |
Description | FUNCTION: RNA helicase involved in mRNA processing and antiviral innate immunity . Pre-mRNA processing factor involved in disassembly of spliceosomes after the release of mature mRNA . In cooperation with TFIP11 seem to be involved in the transition of the U2, U5 and U6 snRNP-containing IL complex to the snRNP-free IS complex leading to efficient debranching and turnover of excised introns . Plays a key role in antiviral innate immunity by promoting both MAVS-dependent signaling and NLRP6 inflammasome . Acts as an RNA virus sensor: recognizes and binds viral double stranded RNA (dsRNA) and activates the MAVS-dependent signaling to produce interferon-beta and interferon lambda-3 (IFNL3) . Involved in intestinal antiviral innate immunity together with NLRP6: recognizes and binds viral dsRNA and promotes activation of the NLRP6 inflammasome in intestinal epithelial cells to restrict infection by enteric viruses . The NLRP6 inflammasome acts by promoting maturation and secretion of IL18 in the extracellular milieu . Also involved in antibacterial innate immunity by promoting Wnt-induced antimicrobial protein expression in Paneth cells (By similarity). . |
Accessions | ENST00000336812.5 O43143 |